This article is more than 5 years old. Information may no longer be current.

Rockwell's second quarter gross profit grows

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

Rockwell Medical reported that gross profit for the second quarter of 2015 increased 2.3% to $2.1 million, compared to the same quarter last year. Revenue for the quarter was 13 million, similar to last year. Research and development expenses for the second quarter were 0.9 million, compared to 0.8 million in 2014. Net loss was $2.5 million or $0.05 per share, compared to a net loss of $3.2 million or $0.08 per share in Q2 2014.

"Our focus and effort the last five months has been on performing the necessary work to launch Triferic commercially, as well as Calcitriol," said Robert L. Chioini, chairman and CEO of Rockwell. -by Rebecca Zumoff

Read also: 2 new studies show benefits of Rockwell’s iron replacement therapy